Inappropriate prescriptions in elderly residents of nursing homes;Prescripciones inapropiadas en ancianos institucionalizados

Revista Espanola de Geriatria y Gerontologia

Volumn 39, Issue 1, 2004, Pages 19-24

  Gongora L ^a   Puche, Emilio ^b   Garcia J ^a   Luna, J D ^b  

^a Residencia La Milagrosa   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Elderly; Inappropriate prescriptions; Nursing home

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; DIPYRIDAMOLE; GASTROINTESTINAL AGENT; HALOPERIDOL; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROCHLOROTHIAZIDE; LIVER PROTECTIVE AGENT; MINERAL; NEUROLEPTIC AGENT; NOOTROPIC AGENT; RANITIDINE; RESERPINE; SPASMOLYTIC AGENT; VASOACTIVE AGENT; VASODILATOR AGENT; VITAMIN; ZOLPIDEM;

AGED; ARTICLE; BEERS SCORE; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG INDUCED DISEASE; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; IATROGENIC DISEASE; INSTITUTIONAL CARE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; MULTICENTER STUDY; NURSING HOME; PRESCRIPTION; PROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SEX DIFFERENCE; SPAIN; STATISTICAL ANALYSIS;

EID: 2442710189     PISSN: 0211139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0211-139x(04)74926-4     Document Type: Article

References (27)

1. Beers M, Ouslander J, Rollinger I, Brooks J, Reuben D, Beck JD. Explicit criteria for determinig inappropriate medication use in nursing homes. Arch Intern Med 1991;151:1825-32.
2. Lindley CM, Tully MP, Paramsothy V, Tallis RC. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992;21:294-300.
3. Stuck A, Beers M, Steiner A, Aronow H, Rubenstein L, Beck J. Inappropriate medication use in community-residing persons. Arch Intern Med 1994;154:2195-200.
4. Spore D, Mor V, Larrat P, Haes C, Hiris J. Inappropriate drug prescriptions for elderly residents of board and care facilities. Am J Public Health; 1997;87:404-9.
5. Straand J, Rokstad K. Elderly patients in general practice: diagnosis, drugs and inappropriate prescriptions. A report from the More & Romsdal prescription study. Fam Practice 1999;16:380-8.
6. Hanlon JT, Schmader KE, Boult C, Artz MB, Fillenbaum GG, Ruby CM, et al. Use inappropriate prescription drugs by older people. J Am Geritr Soc 2002;50:26-34.
7. Golden A, Preston R, Bennet S. Inappropriate medication prescribing housebound older adult. J Am Geriatric Soc 1999;47:948-53.
8. Gill S, Misiaszek B, Brymer G. Improving prescribing in the elderly: a study in the long term care setting. Can J Clin Pharmacol 2001;8:78-83.
9. Avorn J, Gurwitz JH. Drug use in the nursing home. Ann Intern Med 1995;123:195-204.
10. Chutka D, Evans J, Fleming K, Mikkelson K. Drug prescribing for elderly patients. Mayo Clin Proc 1995;70:685-93.
11. Cobos F, Saucedo R, Martínez B, García M, Puche E. Estudio epidemiológico transversal sobre la prescripción médica de fármacos en 415 ancianos domiciliados en residencias para la tercera edad de Granada. Rev Esp Geriatr Gerontol 1996;31:11-5.
12. Hanlon J, Schmader K, Samsa G, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992;45:1045-51.
13. Oborne C, Batty G, Maskrey V, Swift C, Jackson S. Development of prescribing indicators for elderly medical inpatients. Br J Clin Pharmacol 1997;43:91-7.
14. Beers M. Explicit criteria for determinig potentially inappropriate medication use by the elderly. Arch Intern Med 1997;195:1531-3.
15. Aparasu R, Mort J. Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother 2000;34:338-46.
16. Huang B, Bachmann K, He X, Chen R, McAllister J, Wang T. Inappropriate prescriptions for aging population of the Unites States: an analysis of the National Ambulatory Medical Care Survey, 1997. Pharmacoepidemiol Drug Saf 2002;11:127-34.
17. Liu GG, Christensen DB. The continuing challenge of inappropriate prescribing in the elderly: a update of the evidence. J Am Pharm Assoc 2002;42:847-57.
18. Shas S. In praise of the biometric and psychometric quality of the Barthel index. Physiotherapy 1994;80:769-71.
19. Pfeiffer E. A short portable mental status questionnaire for assessment of organic brain deficits in elderly patients. J Am Geriatr Soc 1975;23:433-41.
20. La Corte R, Caselli M, Castellino G, Bajocchi G, Trotta F. Prophylaxis and treatment of NSAID-induced gastroduodenal disorders. Drug Saf 1999;20:527-43.
21. Hanlon J, Fillenbaum G, Kuchibhatla M, Artz M, Boult CH, et al. Impact of inappropriate drug use on mortality and functional status in representative community dwelling elders. Med Care 2002;40:166-76.
22. Holm K, Goa K. Zolpidem. An update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs 2000;59:865-89.
23. Holbrook A, Crowther R, Lotter A, Ciachen Ch, King D. Meta-analysis of benzodiazepine usein the treatment of insomnia. Can J Med Assoc 2002;162:225-34.
24. Smith M, Pedis M, Park A, et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 2002;159:5-11.
25. Flórez J, Dierssen M. Fármacos nootrópicos y neuroprotectores. En: Flórez J, Armijo, Mediavilla, directores. Farmacología humana. 3.o ed. Barcelona: Masson, 1997; p. 593-600.
26. López V, Casellas J, Sardá F, Martín S, García F, Carrasco M. Colitis linfocítica indicida por fármacos flebotónicos. Gastroenterol Hepatol 1997;20:475-6.
27. Ibáñez L, Ballarín E, Vidal X, Laporte JR. Agranulocytosis associated with calcium dobesilate clinical course and risk stimation with the case-control and the case-population approches. Eur J Clin Pharmacol 2000;56:763-7.